Requirement of the Akt/beta-catenin pathway for uterine carcinosarcoma genesis, modulating E-cadherin expression through the transactivation of slug.
about
SLUG: a new target of lymphoid enhancer factor-1 in human osteoblastsThe epithelial-mesenchymal transition (EMT) phenomenonA new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transitionMicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancerHydrogen peroxide mediates EGF-induced down-regulation of E-cadherin expression via p38 MAPK and snail in human ovarian cancer cells.Molecular profiling of endometrial malignancies.Epigenetic silencing of ADAMTS18 promotes cell migration and invasion of breast cancer through AKT and NF-κB signalingGenetics of endometrial cancersEpithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer.Snail family regulation and epithelial mesenchymal transitions in breast cancer progressionIntegrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slugEpithelial-mesenchymal transition (EMT) induced by TNF-α requires AKT/GSK-3β-mediated stabilization of snail in colorectal cancerFibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cellsCombination of rapamycin, CI-1040, and 17-AAG inhibits metastatic capacity of prostate cancer via Slug inhibition.FilGAP, a Rac-specific Rho GTPase-activating protein, is a novel prognostic factor for follicular lymphoma.Zipper-interacting protein kinase promotes epithelial-mesenchymal transition, invasion and metastasis through AKT and NF-kB signaling and is associated with metastasis and poor prognosis in gastric cancer patients.Malignant mixed Mullerian tumour of uterus secondary to tamoxifen therapy for hormone responsive breast cancerCooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma.Breast cancer stem cells, pathways and therapeutic perspectives 2011.Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.Slug inhibits the proliferation and tumor formation of human cervical cancer cells by up-regulating the p21/p27 proteins and down-regulating the activity of the Wnt/β-catenin signaling pathway via the trans-suppression Akt1/p-Akt1 expression.SPANXA suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung adenocarcinoma.The biology of uterine sarcomas: A review and update.Epithelial to mesenchymal transition in the pathogenesis of uterine malignant mixed Müllerian tumours: the role of ubiquitin proteasome system and therapeutic opportunities.Epithelial-mesenchymal transition in carcinomas of the female genital tract.Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives.Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.Analysis of differentially expressed genes between endometrial carcinosarcomas and endometrioid endometrial carcinoma by bioinformatics.Transcriptional upregulation of HNF-1β by NF-κB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression.Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancer.Transcriptional upregulation of HIF-1α by NF-κB/p65 and its associations with β-catenin/p300 complexes in endometrial carcinoma cells.Sox4 functions as a positive regulator of β-catenin signaling through upregulation of TCF4 during morular differentiation of endometrial carcinomas.Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component.Transcription factor Snai1-1 induces osteosarcoma invasion and metastasis by inhibiting E-cadherin expressionA Regulatory Network Involving β-Catenin, e-Cadherin, PI3k/Akt, and Slug Balances Self-Renewal and Differentiation of Human Pluripotent Stem Cells In Response to Wnt Signaling.Tumor necrosis factor-α induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism.Downregulation of Bit1 expression promotes growth, anoikis resistance, and transformation of immortalized human bronchial epithelial cells via Erk activation-dependent suppression of E-cadherin.FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction.Transcriptional regulation of pro-apoptotic Par-4 by NF-kappaB/p65 and its function in controlling cell kinetics during early events in endometrial tumourigenesis.
P2860
Q24298265-6B9F6941-D946-40FF-92C2-6C98BEF891E9Q24600898-42B354DE-946A-4A3B-9883-C020A12B2560Q26799171-3B5F5D1F-0D7B-4E33-9471-CDFE0C435F86Q33590704-02650DC6-4C94-4798-AD2E-5CABDD406E11Q33637424-317D8E3D-235C-44E8-8ABC-E3127D78A554Q33757898-44D11373-61AD-4360-8EE2-AAB35A8AEEC2Q33775271-1CB643C6-55F4-46DA-9307-6812D332B101Q33781274-E72B4B49-F0CE-4696-904D-6087F9E18214Q33872622-B0EA0651-3486-4D5D-80E4-1657140703D5Q34091442-8117C1BC-F5E7-4C75-8449-31A73F6FB75BQ34095480-ECA14643-36D0-4566-8469-18D5782273DCQ34320700-338FF3E7-10B9-406C-8576-224926AE7BB1Q34595133-152D330C-CC76-4C7E-98C5-0565BBB1BC6DQ34648726-E829B550-BF8C-4C8C-98C8-71767C16B3B1Q35018858-27D0DD19-336B-4B54-8781-E66DCD50C9CEQ35755363-300A0DBB-FF19-4FD5-9773-FBAA5FA39EEAQ35781586-6B80D19A-AD81-455B-B554-6F1050E55E28Q35808387-3F20B512-02B6-472C-857E-F7AF5DB0925CQ35913708-30C329AB-A56F-426B-8837-7124269FC1E5Q36946326-D9EBD56E-3BC2-473D-8EB4-E7F75E0056F3Q37225403-605A817A-603B-464C-831B-EED2DAA120C7Q37295608-AE427F87-BB98-41A3-AC1D-694338E793BDQ37536912-C21DB494-40CE-4EB1-9CC4-F37E59CF76D8Q37562600-78E47215-4749-488B-B6E1-2D8DB90F952AQ38000940-2672B160-5F49-46A9-B91E-84705B0F1B2EQ38067434-7533F74D-4532-41E6-9DF2-D651D54FC2E2Q38244309-3B2BE351-401C-4DA4-BC9A-EE8A392748B6Q38305458-FE74EA50-5706-4888-B69F-492500A1CE14Q38457773-7FCE1F97-4434-4C25-975F-9C40459DF466Q38868955-A0D6D9CB-4075-4FEF-96AF-FEBA6395469FQ38965263-C5DE8982-46FD-4B8F-A8E6-6C51C3310DE6Q39094933-2D20EEE1-C3C9-44F1-9F92-3FBDA8AE7386Q39414697-DDB44D4D-1534-48C8-8749-BED272162E5EQ39750078-961B6020-A659-4EDC-9C5B-4578BE1C6CA4Q40892422-57105A26-6F1F-4CA6-AD6C-2690E6FAFCFFQ42323181-0A219B44-48E2-418D-B384-D7E4037413D9Q46498246-2B5E3CB3-2C95-41FE-8713-6EDA3C18B249Q46618953-1ABEF6C8-7FB3-4BDB-B57C-BFAFB823E0C7Q48259597-4C0FB0B2-DA4F-486B-9A23-3058A25CA94EQ53301550-EC7D2DD7-360C-4E79-9A68-3477753A3381
P2860
Requirement of the Akt/beta-catenin pathway for uterine carcinosarcoma genesis, modulating E-cadherin expression through the transactivation of slug.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Requirement of the Akt/beta-ca ...... h the transactivation of slug.
@en
Requirement of the Akt/beta-ca ...... h the transactivation of slug.
@nl
type
label
Requirement of the Akt/beta-ca ...... h the transactivation of slug.
@en
Requirement of the Akt/beta-ca ...... h the transactivation of slug.
@nl
prefLabel
Requirement of the Akt/beta-ca ...... h the transactivation of slug.
@en
Requirement of the Akt/beta-ca ...... h the transactivation of slug.
@nl
P2093
P2860
P1476
Requirement of the Akt/beta-ca ...... h the transactivation of slug.
@en
P2093
Isao Okayasu
Makoto Saegusa
Miki Hashimura
Takeshi Kuwata
P2860
P304
P356
10.2353/AJPATH.2009.081018
P407
P577
2009-04-23T00:00:00Z